United States of America ex rel. Steven M. Camburn et al. v. Novartis Pharmaceuticals Corporation

Filing 84

ORDER EXTENDING TIME TO RESPOND TO THIRD AMENDED COMPLAINT, SETTING A BRIEFING SCHEDULE AND EXTENDING PAGE LIMITS: it is ORDERED AS FOLLOWS: The request is GRANTED. Defendant shall respond to the Third Amended Complaint by January 3, 2022. The Court establishes the following briefing schedule and page limits with respect to any motion to dismiss the Third Amended Complaint: Defendant may file a Memorandum of Law in Support of a Motion to Dismiss the Third Amended Complaint that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); Within thirty (30) days of Defendant's Motion to Dismiss, Plaintiff- Relator may file a Memorandum of Law in Opposition to Defendant's Mo tion to Dismiss that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); Within fourteen (14) days of Plaintiff Relator's opposition, Defendant may file a Memorandum of Law in R eply that shall not exceed twenty (20) pages (excluding the caption, table of contents, table of authorities and signature block). SO ORDERED., Novartis Pharmaceuticals Corporation answer due 1/3/2022. (Signed by Judge Kimba M. Wood on 11/29/2021) (ama)

Download PDF
Case 1:13-cv-03700-KMW-GWG Document 84 Filed 11/29/21 Page 1 of 2 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK UNITED STATES OF AMERICA; the States of CALIFORNIA, COLORADO, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, HAWAII, ILLINOIS, INDIANA, IOWA, LOUISIANA, MASSACHUSETTS, MICHIGAN, MINNESOTA, MONTANA, NEVADA, NEW JERSEY, NEW MEXICO, NEW YORK, NORTH CAROLINA, OKLAHOMA, RHODE ISLAND, TENNESSEE, TEXAS, VIRGINIA, WASHINGTON and WISCONSIN; the DISTRICT OF COLUMBIA, THE CITY OF CHICAGO and THE CITY OF NEW YORK; ex rel., STEVEN M. CAMBURN, USDC SDNY DOCUMENT ELECTRONICALLY FILED DOC #: DATE FILED: 11/29/2021 No. 13 Civ. 3700 (KMW) (GWG) Plaintiffs and Relator, vs. NOVARTIS PHARMACEUTICALS CORPORATION, Defendant. ORDER EXTENDING TIME TO RESPOND TO THIRD AMENDED COMPLAINT, SETTING A BRIEFING SCHEDULE AND EXTENDING PAGE LIMITS Upon consideration of the parties’ joint request for an extension of time for Defendant’s response to the Third Amended Complaint and for a briefing schedule and extension of page limits for any motion to dismiss filed in response to the Third Amended Complaint, it is ORDERED AS FOLLOWS: The request is GRANTED. Defendant shall respond to the Third Amended Complaint by January 3, 2022. The Court establishes the following briefing schedule and page limits with respect to any motion to dismiss the Third Amended Complaint: Case 1:13-cv-03700-KMW-GWG Document 84 Filed 11/29/21 Page 2 of 2 4 1. Defendant may file a Memorandum of Law in Support of a Motion to Dismiss the Third Amended Complaint that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); 2. Within thirty (30) days of Defendant’s Motion to Dismiss, PlaintiffRelator may file a Memorandum of Law in Opposition to Defendant’s Motion to Dismiss that shall not exceed fifty (50) pages (excluding the caption, table of contents, table of authorities and signature block); 3. Within fourteen (14) days of Plaintiff-Relator’s opposition, Defendant may file a Memorandum of Law in Reply that shall not exceed twenty (20) pages (excluding the caption, table of contents, table of authorities and signature block). November 29 SO ORDERED this _______ day of ________________, 2021. /s/ Kimba M. Wood The Honorable Kimba M. Wood

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?